Back to Screener

Healthcare

Berkeley Lights, Inc.(BLI)

Live Price

Offline

$1.20

-5.88% today

1Y Change

Window

No data

Market Cap
$86.61M
Revenue Growth
-8.0%
EPS Growth
-31.5%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Berkeley Lights, Inc. (BLI) is a Healthcare stock with a market cap of $86.61M. The stock last traded around $1.20. Baseline metrics include revenue growth of -8.0%, EPS growth of -31.5%, a dividend yield of 0.0%. What stands out right now is revenue -8.0%, EPS -31.5%, free cash flow +19.3% with operating margin -120.3% and ROIC -50.9%. Valuation is more restrained than many high-expectation growth names at price/sales 1.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BLI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

BLI

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

BLI Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BLI and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Berkeley Lights, Inc. (BLI)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$31.3M

-44.8% YoY

FY Net Income

-$23.3M

-27.5% YoY

Free Cash Flow

-$21.0M

-10.5% YoY

Revenue Growth

-8.0%

EPS Growth

-31.5%

Gross Margin

68.4%

Net Margin

-124.7%

Income statement

USD

Annual
Metric20222021202020192018
Revenue79M85M64M57M31M
Gross Profit54M57M45M43M23M
Operating Income-95M-71M-40M-17M-21M
EBITDA-92M-70M-40M-11M-17M
Net Income-98M-72M-42M-18M-23M
EPS (Diluted)

Balance sheet

USD

Point-in-time
Metric20222021202020192018
Cash & Equivalents87M178M233M81M100M
Total Assets226M287M300M131M134M
Total Liabilities84M79M55M47M36M
Shareholder Equity142M208M245M84M98M
Total Debt43M44M36M29M20M
Net Debt-44M-134M-198M-52M-80M

Cash flow positioning

Latest Full Year

Operating Cash Flow

14M

-28.5% YoY

Capital Expenditures

7M

+11.9% YoY

Free Cash Flow

21M

-10.5% YoY

Key ratios

  • Gross Margin

    68.4%

  • Operating Margin

    -120.3%

  • Net Margin

    -124.7%

  • ROE

    -56.0%

  • Debt / Equity

    0.30x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.